LPU
AGN

Lansdowne Partners (UK)’s Allergan plc AGN Stock Holding History

Lansdowne Partners (UK)’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-4,010
Closed -$656K – 54
2017
Q4 		$656K Hold
4,010
– – 0.01% 46
2017
Q3 		$822K Hold
4,010
– – 0.01% 50
2017
Q2 		$975K Hold
4,010
– – 0.01% 45
2017
Q1 		$958K Buy
+4,010
New +$934K 0.01% 45

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return

Lansdowne Partners (UK)'s AGN Position: Q1 2018 in Review

Lansdowne Partners (UK) sold out of Allergan plc (AGN) in Q1 2018, closing a stake of 4,010 shares — an estimated $656K sold.

Lansdowne Partners (UK) first reported a position in AGN in Q1 2017 and held it in 4 quarters. The position peaked at $975K in Q2 2017. 1,022 funds tracked by Wall St. Rank hold AGN as of Q1 2018.

  • Lansdowne Partners (UK) reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
  • Lansdowne Partners (UK) sold 4,010 Allergan plc shares in Q1 2018, an estimated $656K.
  • Lansdowne Partners (UK) first reported a position in Allergan plc in Q1 2017 and held it in 4 quarters.
  • Lansdowne Partners (UK)'s Allergan plc position peaked at $975K in Q2 2017.
  • 1,022 funds tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Lansdowne Partners (UK)'s 13F filing for Q1 2018, filed 14 May 2018.